Osaic Holdings’s Cidara Therapeutics CDTX Stock Holding History

Osaic Holdings’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$15.8K	–	7846
2025 Q4	$15.8K	Buy	+1	New	+$162	﹤0.01%	6021

Osaic Holdings's CDTX Position: Q1 2026 in Review

Osaic Holdings sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 48 shares — an estimated $10.6K sold.

Osaic Holdings first reported a position in CDTX in Q2 2020 and held it in 16 quarters. The position peaked at $58.6K in Q2 2023. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Osaic Holdings reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Osaic Holdings sold 48 Cidara Therapeutics shares in Q1 2026, an estimated $10.6K.
Osaic Holdings first reported a position in Cidara Therapeutics in Q2 2020 and held it in 16 quarters.
Osaic Holdings's Cidara Therapeutics position peaked at $58.6K in Q2 2023.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.